{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:33:34Z","timestamp":1793669614772,"version":"4.5.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ophtha.2013.11.017","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T05:30:14Z","timestamp":1389245414000},"page":"994-1000","source":"Crossref","is-referenced-by-count":131,"title":["Surgical versus Medical Treatment of Ocular Surface Squamous Neoplasia"],"prefix":"10.1016","volume":"121","author":[{"given":"Afshan A.","family":"Nanji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina S.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Galor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Oellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Karp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2013.11.017_bib1","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/ijc.23384","article-title":"Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States","volume":"122","author":"Guech-Ongey","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ophtha.2013.11.017_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/CCO.0b013e32833cfcf9","article-title":"Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa","volume":"22","author":"Nagaiah","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ophtha.2013.11.017_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archopht.1992.01080160103042","article-title":"Incidence of ocular surface epithelial dysplasia in metropolitan Brisbane. A 10-year survey","volume":"110","author":"Lee","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.11.017_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ijc.25040","article-title":"A\u00a0case-control study of ocular surface squamous neoplasia (OSSN) in Uganda","volume":"127","author":"Waddell","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ophtha.2013.11.017_bib5","first-page":"27","article-title":"Factors associated with conjunctival intraepithelial neoplasia: a case control study","volume":"21","author":"Napora","year":"1990","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.ophtha.2013.11.017_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1442-9071.1997.tb01514.x","article-title":"Retrospective study of ocular surface squamous neoplasia","volume":"25","author":"Lee","year":"1997","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.11.017_bib7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0161-6420(01)00991-5","article-title":"Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia","volume":"109","author":"Scott","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.11.017_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1309\/RVUP-QMU3-5X6W-3CQ1","article-title":"Failure to detect human papillomavirus DNA in malignant epithelial neoplasms of conjunctiva by polymerase chain reaction","volume":"117","author":"Eng","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ophtha.2013.11.017_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/bjo.87.4.396","article-title":"Risk factors for conjunctival squamous cell neoplasia: a matched case-control study","volume":"87","author":"Tulvatana","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.11.017_bib10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/02713680903007162","article-title":"No evidence for a pathogenic role of human papillomavirus infection in ocular surface squamous neoplasia in Germany","volume":"34","author":"Guthoff","year":"2009","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2013.11.017_bib11","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.5858\/133.8.1246","article-title":"Lack of association of high-risk human papillomavirus in ocular surface squamous neoplasia in India","volume":"133","author":"Manderwad","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ophtha.2013.11.017_bib12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archopht.1997.01100150810025","article-title":"Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture","volume":"115","author":"Shields","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.11.017_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0161-6420(97)30287-5","article-title":"Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia","volume":"104","author":"Tabin","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.11.017_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/sj.eye.6700331","article-title":"Excision and cryosurgery in the treatment of conjunctival malignant epithelial tumours","volume":"17","author":"Peksayar","year":"2003","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2013.11.017_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00003226-200201000-00004","article-title":"The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation","volume":"21","author":"Siganos","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.11.017_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/bjo.84.3.268","article-title":"Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil","volume":"84","author":"Midena","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.11.017_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.ico.0000138834.42489.ba","article-title":"Ocular surface squamous neoplasia: a standard of care survey","volume":"24","author":"Stone","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.11.017_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/IOP.0b013e3181ac4c39","article-title":"Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia","volume":"25","author":"Ballalai","year":"2009","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ophtha.2013.11.017_bib19","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0161-6420(97)30055-4","article-title":"Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience","volume":"104","author":"Frucht-Pery","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.11.017_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/bjo.2008.153197","article-title":"Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study","volume":"94","author":"Galor","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.11.017_bib21","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.ophtha.2010.03.052","article-title":"Subconjunctival\/perilesional recombinant interferon alpha2b for ocular surface squamous neoplasia: a 10-year review","volume":"117","author":"Karp","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.11.017_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/09273948.2010.486687","article-title":"Pegylated interferon alpha 2b for treatment of ocular surface squamous neoplasia: a pilot study","volume":"18","author":"Karp","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2013.11.017_bib23","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0161-6420(00)00389-4","article-title":"5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea","volume":"107","author":"Yeatts","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.11.017_bib24","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0161-6420(95)30866-4","article-title":"Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea","volume":"102","author":"Yeatts","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.11.017_bib25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.ophtha.2007.10.039","article-title":"Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b","volume":"115","author":"Schechter","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.11.017_bib26","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ophtha.2008.01.006","article-title":"Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia","volume":"115","author":"Sturges","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.11.017_bib27","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.1991.03470100067035","article-title":"The interferons: mechanisms of action and clinical applications","volume":"266","author":"Baron","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2013.11.017_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejca.2009.10.013","article-title":"Redefining the role of interferon in the treatment of malignant diseases","volume":"46","author":"Bracarda","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ophtha.2013.11.017_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00063030-200216040-00003","article-title":"Potential of interferon-alpha in solid tumours: part 1","volume":"16","author":"Decatris","year":"2002","journal-title":"BioDrugs"},{"key":"10.1016\/j.ophtha.2013.11.017_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00063030-200216050-00004","article-title":"Potential of interferon-alpha in solid tumours: part 2","volume":"16","author":"Santhanam","year":"2002","journal-title":"BioDrugs"},{"key":"10.1016\/j.ophtha.2013.11.017_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0161-6420(99)90009-X","article-title":"Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia","volume":"106","author":"Vann","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.11.017_bib32","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.ophtha.2012.04.022","article-title":"Predictors of ocular surface squamous neoplasia recurrence after excisional surgery","volume":"119","author":"Galor","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.11.017_bib33","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC Cancer Staging Manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ophtha.2013.11.017_bib34","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.ophtha.2004.01.034","article-title":"Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b","volume":"111","author":"Boehm","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.11.017_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archophthalmol.2011.385","article-title":"Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification","volume":"130","author":"Shah","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.11.017_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICO.0b013e3182523f61","article-title":"Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification","volume":"32","author":"Shields","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.11.017_bib37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00003226-200310000-00015","article-title":"Ocular surface squamous neoplasia: a review","volume":"22","author":"Basti","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.11.017_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00003226-200201000-00003","article-title":"Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b","volume":"21","author":"Schechter","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.11.017_bib39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ajo.2006.05.058","article-title":"Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia","volume":"142","author":"Holcombe","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.11.017_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ophtha.2011.08.005","article-title":"Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases","volume":"119","author":"Yousef","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.11.017_bib41","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ophtha.2011.11.035","article-title":"Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction","volume":"119","author":"Kim","year":"2012","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642013010798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642013010798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T15:21:24Z","timestamp":1716391284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642013010798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0161642013010798"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2013.11.017","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718235777.793498111","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}